Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Biochem Pharmacol. 2016 Dec 8;126:51–68. doi: 10.1016/j.bcp.2016.12.003

Fig. 3.

Fig. 3

Evaluation of the antiproliferative effects of 1 in cancer cells. Effect of pachycladin A treatment on the growth of (A) MDA-MB-231, (B) MDA-MB-468, (C) BT-474, (D) MCF-7, (E) SKBR3 and (F) T-47D breast cancer cells after 48 h. Effect of pachycladin A treatment on the growth of HeLa cervical cancer cells after (G) 48 and (H) 72 h. Viable cell count was determined using MTT assay. Error bars indicate the S.D. of N=3/dose. Oleocanthal and nocodazole were used as positive controls at doses selected based on earlier studies [20, 21].